anti clotting drugs Flashcards

1
Q

Name the type of anti clotting drugs

A
  1. antiplatelets
  2. anti coagulants
  3. anti thrombin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Name the classes of antiplatelet drug

A
  1. NSAID : aspirin
  2. platelet GPIIa/b receptors blocker
  3. ADP blocker
  4. PDE inhibitor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Aspirin MOA

A

inhibit cyclooxygenase, inhibit conversion of arachidonic acid into prostaglandin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Aspirin clinical uses

A
  1. prophylaxis for cerebral ischemia
  2. prevent recurrent myocardial infarction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Aspirin adverse effects

A
  1. GI bleeding and ulcers
  2. bruising and bleeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are GPIIa/b receptors

A
  • platelet membrane surface proteins
  • mainly for fibrinogen
  • activation of receptor complex is the final common pathway of platelet aggregation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Name 3 platelet GPIIa/b receptor blockers

A

ATE
1. Abciximab : humanised monoclonal ab
2. Tirofiban: small molecule blocker
3. Eptifibatide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Platelet GPIIa/b receptor blockers clinical uses

A

prevent restenosis
used for acute coronary syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Name 2 ADP receptor blockers

A
  1. clopidogrel
  2. ticlopidine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ADP receptor blockers MOA

A

prevents ADP from binding to ADP receptor, prevent activation of platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Name a PDE inhibitor

A

dipyridamole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Dipyridamole MOA

A
  • inhibits phosphodiesterase
  • prevents breakdown of cAMP
  • increase levels of cAMP in platelets
  • decrease platelet aggregation and adhesion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Name the anticoagulants

A
  1. heparin
  2. wafarin
  3. anti thrombin III
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Heparin MOA

A
  • heparin binds to ATIII, causing conformational change to ATIII active site, exposing it to the enzyme (thrombin factor IIa)
  • heparin is also required to bind to the protease to inhibit thrombin
  • inhibit conversion of fibrinogen to fibrin
  • prevent clotting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Heparin clinical uses

A
  1. deep vein thrombosis
  2. pulmonary embolism
  3. actue myocardial infarction
    - can be used in pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Heparin bioavailability

A
  • given IV/ subcutaneous
    given IM during haematomas
13
Q

Heparin adverse effect

A
  1. thrombocytopaenia
  2. haemorrhage
    - stop heparin and use protamine sulfate (antidote for heparin)
13
Q

Warfarin MOA

A
  • inhibit vitamin K reductase: convert vit K into its active form
    (vit K is essential for formation of clotting factors 2,9,10,12)
  • reduce vit K available in liver
  • decrease activation of clotting factors
14
Q

warfarin clinical uses

A

same as heparin
CANNOT BE USED IN PREGNANCY

15
Q

wafarin adverse effects

A
  1. bleeding
  2. cross placenta and cause haemorrhagic disorder in fetus
  3. hep clearance by cytochrome P450 : DDI!!!!
16
Q

Name 4 thrombolytic agents

A
  1. tissue plasminogen activator (alteplase)
  2. urokinase
  3. streptokinase
  4. anistreplase
17
Q

thrombolytic agents MOA

A
  • activate plasminogen into its active form plasmin
  • plasmin cleaves fibrin which is the main component of the clot
18
Q

thrombolytic agents bioavailability

A
  1. IV injection
  2. intracoronary injection
19
Q

thrombolytic agent clinical uses

A
  1. emergency treatement of coronary artery thrombosis
  2. peripheral arterial thrombosis and emboli
  3. ischaemic stroke (<4.5 h)
20
Q

thrombolytic agent adverse effects

A
  1. bleeding
  2. impaired wound healing
  3. contraindicated in pregnancy